Are circulating immune cells a determinant of pancreatic cancer risk? A prospective study using epigenetic cell count measures.
Autori:
Katzke V, Le Cornet C, Mahfouz R, Brauer B, Johnson T, Canzian F, Rebours V, Boutron-Ruault MC, Severi G, Schulze MB, Olsen A, Tjoenneland A, Overvad K, Crous-Bou M, Molina-Montes E, Amiano P, Huerta JM, Ardanaz E, Perez-Cornago A, Masala G, Pala V, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, Vermeulen R, Sund M, Franklin O, Christakoudi S, Dossus L, Weiderpass E, Olek S, Kaaks R.
Rivista:
Cancer Epidemiol Biomarkers Prev 2021 Sep 20:cebp.0169.2021. doi: 10.1158/1055-9965.EPI-21-0169. Online ahead of print. PMID: 34548327 (IF 4.254)